NAB2
NGFI-A-binding protein 2 also known as EGR-1-binding protein 2 or melanoma-associated delayed early response protein (MADER) is a protein that in humans is encoded by the NAB2 gene.[5][6][7]
Function
[edit]This gene encodes a member of the family of NGFI-A binding (NAB) proteins, which function in the nucleus to repress or activate transcription induced by some members of the EGR (early growth response) family of transactivators. NAB proteins can homo- or hetero-multimerize with other EGR or NAB proteins through a conserved N-terminal domain, and repress transcription through two partially redundant C-terminal domains. Transcriptional repression by the encoded protein is mediated in part by interactions with the nucleosome remodeling and deactylase (NuRD) complex. Alternatively spliced transcript variants have been described, but their biological validity has not been determined.[7]
Pathology
[edit]Recurrent somatic fusions of the two genes, NGFI-A–binding protein 2 (NAB2) and STAT6, located at chromosomal region 12q13, have been identified in solitary fibrous tumors.[8]
References
[edit]- 1 2 3 GRCh38: Ensembl release 89: ENSG00000166886 – Ensembl, May 2017
- 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000025402 – Ensembl, May 2017
- ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ Svaren J, Sevetson BR, Apel ED, Zimonjic DB, Popescu NC, Milbrandt J (August 1996). "NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli". Molecular and Cellular Biology. 16 (7): 3545–3553. doi:10.1128/MCB.16.7.3545. PMC 231349. PMID 8668170.
- ↑ Kirsch KH, Korradi Y, Johnson JP (July 1996). "Mader: a novel nuclear protein over expressed in human melanomas". Oncogene. 12 (5): 963–971. PMID 8649813.
- 1 2 "Entrez Gene: NAB2 NGFI-A binding protein 2 (EGR1 binding protein 2)".
- ↑ Kabbinavar FF, Hambleton J, Mass RD, Hurwitz HI, Bergsland E, Sarkar S (June 2005). "Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer". Journal of Clinical Oncology. 23 (16): 3706–3712. doi:10.1200/JCO.2005.00.232. PMID 15867200.
Further reading
[edit]- Svaren J, Apel ED, Simburger KS, Jenkins NA, Gilbert DJ, Copeland NA, et al. (April 1997). "The Nab2 and Stat6 genes share a common transcription termination region". Genomics. 41 (1): 33–39. doi:10.1006/geno.1997.4609. PMID 9126479.
- Qu Z, Wolfraim LA, Svaren J, Ehrengruber MU, Davidson N, Milbrandt J (August 1998). "The transcriptional corepressor NAB2 inhibits NGF-induced differentiation of PC12 cells". The Journal of Cell Biology. 142 (4): 1075–1082. doi:10.1083/jcb.142.4.1075. PMC 2132876. PMID 9722618.
- Svaren J, Sevetson BR, Golda T, Stanton JJ, Swirnoff AH, Milbrandt J (October 1998). "Novel mutants of NAB corepressors enhance activation by Egr transactivators". The EMBO Journal. 17 (20): 6010–6019. doi:10.1093/emboj/17.20.6010. PMC 1170927. PMID 9774344.
- Abdulkadir SA, Qu Z, Garabedian E, Song SK, Peters TJ, Svaren J, et al. (January 2001). "Impaired prostate tumorigenesis in Egr1-deficient mice". Nature Medicine. 7 (1): 101–107. doi:10.1038/83231. PMID 11135623. S2CID 7191051.
- Abdulkadir SA, Carbone JM, Naughton CK, Humphrey PA, Catalona WJ, Milbrandt J (September 2001). "Frequent and early loss of the EGR1 corepressor NAB2 in human prostate carcinoma". Human Pathology. 32 (9): 935–939. doi:10.1053/hupa.2001.27102. PMID 11567222.
- Venken K, Di Maria E, Bellone E, Balestra P, Cassandrini D, Mandich P, et al. (March 2002). "Search for mutations in the EGR2 corepressor proteins, NAB1 and NAB2, in human peripheral neuropathies". Neurogenetics. 4 (1): 37–41. doi:10.1007/s10048-001-0124-2. PMID 12030330. S2CID 1928229.
- Lucerna M, Mechtcheriakova D, Kadl A, Schabbauer G, Schäfer R, Gruber F, et al. (March 2003). "NAB2, a corepressor of EGR-1, inhibits vascular endothelial growth factor-mediated gene induction and angiogenic responses of endothelial cells". The Journal of Biological Chemistry. 278 (13): 11433–11440. doi:10.1074/jbc.M204937200. PMID 12427750.
- Kumbrink J, Gerlinger M, Johnson JP (2005). "Egr-1 induces the expression of its corepressor nab2 by activation of the nab2 promoter thereby establishing a negative feedback loop". The Journal of Biological Chemistry. 280 (52): 42785–42793. doi:10.1074/jbc.M511079200. PMID 16260776.
- Kimura K, Wakamatsu A, Suzuki Y, Ota T, Nishikawa T, Yamashita R, et al. (January 2006). "Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes". Genome Research. 16 (1): 55–65. doi:10.1101/gr.4039406. PMC 1356129. PMID 16344560.
- Srinivasan R, Mager GM, Ward RM, Mayer J, Svaren J (June 2006). "NAB2 represses transcription by interacting with the CHD4 subunit of the nucleosome remodeling and deacetylase (NuRD) complex". The Journal of Biological Chemistry. 281 (22): 15129–15137. doi:10.1074/jbc.M600775200. PMID 16574654.
- Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, et al. (November 2006). "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks". Cell. 127 (3): 635–648. doi:10.1016/j.cell.2006.09.026. PMID 17081983. S2CID 7827573.